Prosecution Insights
Last updated: August 18, 2026

Examiner: NICOL, ALEXANDER W

Tech Center 1600 • Art Units: 1633 1634

This examiner grants 43% of resolved cases

Performance Statistics

42.9%
Allow Rate
-17.1% vs TC avg
232
Total Applications
+43.1%
Interview Lift
1504
Avg Prosecution Days
Based on 177 resolved cases, 2023–2026

Rejection Statute Breakdown

3.1%
§101 Eligibility
19.5%
§102 Novelty
40.9%
§103 Obviousness
21.3%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18566367 CAS9 NICKASE-MEDIATED GENE EDITING Non-Final OA UNIVERSITY OF MASSACHUSETTS
18538799 THERAPEUTIC COMPOSITIONS COMPRISING TRANSCRIPTION FACTORS AND METHODS OF MAKING AND USING THE SAME Non-Final OA The Regents of the University of California
18034045 CONTROLLING CELLULAR BEHAVIOR USING FEED-FORWARD CIRCUITS Final Rejection The Regents of the University of California
18049834 OVEREXPRESSION OF LEMD2, LEMD3, OR CHMP7 AS A THERAPEUTIC MODALITY FOR TAUOPATHY Final Rejection REGENERON PHARMACEUTICALS, INC.
17244136 COMPOSITIONS AND METHODS FOR INHIBITION OF LINEAGE SPECIFIC ANTIGENS Non-Final OA The Trustees of Columbia University in the City of New York
17152463 ADENO-ASSOCIATED VIRAL VECTOR, COMPOSITIONS, METHODS OF PROMOTING MUSCLE REGENERATION, AND TREATMENT METHODS Final Rejection NEW YORK UNIVERSITY
17793115 SMALL TYPE II-D CAS PROTEINS AND METHODS OF USE THEREOF Final Rejection MASSACHUSETTS INSTITUTE OF TECHNOLOGY
17616111 NOVEL LIVE-CELL ASSAY FOR NEURONAL ACTIVITY Non-Final OA UNIVERSITY OF UTAH RESEARCH FOUNDATION
18020029 COMPOSITIONS AND METHODS FOR INCREASING PROTEIN EXPRESSION Final Rejection The Hong Kong University of Science and Technology
18282463 CHARACTERIZING THE BINDING INTERACTIONS BETWEEN MUSK AND BMP RECEPTORS Final Rejection Brown University
18252194 EXPRESSION SYSTEM AND METHOD FOR CONTROLLING A NETWORK IN A CELL AND CELL COMPRISING THE EXPRESSION SYSTEM Final Rejection ETH ZURICH
17055075 CRISPR INTERFERENCE BASED HTT ALLELIC SUPPRESSION AND TREATMENT OF HUNTINGTON DISEASE Final Rejection THE CHILDREN'S HOSPITAL OF PHILADELPHIA

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month